Author

R. Jordan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:bacteria (other)· 1 Organism:non-human primate· 1

Frequent Co-Authors

A. A. Krikunov· 1 shared A. Garg· 1 shared A. Kamyshnyi· 1 shared A. Silva Pena· 1 shared A. Spiers· 1 shared A. V. Kabanov· 1 shared C. C. Stobart· 1 shared D. Hwang· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. A. Krikunov

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Poly(2-oxazoline)-based polyplexes as a PEG-free plasmid DNA delivery platform

D. Yamaleyeva, N. Makita, D. Hwang, M. Haney, R. Jordan, A. V. Kabanov

This study develops PEG-free poly(2-oxazoline) copolymers for efficient plasmid DNA delivery to immune cells, finding that DET-based diblock copolymers outperform other structures in macrophage transfection.

bioRxiv · Dec 18, 2022Bioengineering

Azithromycin possesses biofilm-inhibitory activity and potentiates non-bactericidal colistin methanesulfonate against Klebsiella pneumonia

O. V. Moshynets, T. P. Baranovskyi, S. Cameron, O. S. Iugin, I. Pokholenko, R. Jordan, A. Kamyshnyi, A. A. Krikunov, V. V. Potochilova, K. L. Rudnieva, A. Spiers

The paper shows azithromycin inhibits biofilm growth and enhances colistin methanesulfonate's effectiveness against Klebsiella pneumoniae biofilms.

bioRxiv · Feb 17, 2022 · PreprintMicrobiology

One mucosal administration of a live attenuated recombinant COVID-19 vaccine protects non-human primates from SARS-CoV-2

M. F. Tioni, R. Jordan, A. Silva Pena, A. Garg, D. Wu, S. I. Phan, X. Cheng, J. Greenhouse, T. Orekov, D. Valentin, S. Kar, L. Pessaint, H. Andersen, C. C. Stobart, M. H. Bloodworth, , R. S. Tang

This study shows that a single mucosal dose of the live attenuated RSV-based vaccine MV-014-212 protects non-human primates from SARS-CoV-2 infection by reducing viral shedding and inducing neutralizing antibodies.

bioRxiv · Jul 16, 2021Immunology